In Silico Binding Mode Analysis of Blarina Paralytic Peptides with the Human T-Type Ca Channel hCav3.2
Toxins · 04.11.2025 · 17 (11) · 549
DOI: 10.3390/toxins17110549 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, online erschienen am 04.11.2025. Verfasst von Nozomi Hara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa, Nagoya 464-8601, Japan. Hauptthemen laut MEDLINE: Calcium Channels, T-Type, Neurotoxins, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Astellas Foundation for Research on Metabolic Disorders, Daiichi Sankyo Foundation of Life Science.
Abstract (Originalsprache)
Blarina paralytic peptides (BPPs), neurotoxins from shrew saliva that paralyze mealworms, share high sequence similarity with human synenkephalin [1–53] (hSYN), a peptide released from proenkephalin together with opioid peptides that mediate analgesic and antidepressant effects in the brain. Both synthetic BPP2 and hSYN induce a hyperpolarizing shift in the human T-type voltage-gated calcium channel (hCav3.2) at sub-micromolar concentrations, although only BPP2 causes paralysis in insects. To gain insight into the functions of these insectivorous animal-specific neurotoxins and the largely uncharacterized brain peptides, we investigated the structure prediction of BPPs and SYNs and their interactions with hCav3.2. AlphaFold 3 modeling complemented available cryo-EM data and accurately reproduced the overall channel architecture; however, this inactivated-state model proved unsuitable for predicting agonistic binding of BPPs and SYNs. In contrast, docking simulations using an activated-state hCav3.2 homology model revealed distinct ligand-dependent differences in binding energies, affinity, and conformational flexibility. Notably, the C-terminal tail of BPPs—particularly its variable length and flexibility—was identified as a key determinant for the interactions with the S4 voltage-sensing domain of the channel. These findings provide new insights into the evolutionary adaptation of venom peptides in mammals and into potential therapeutic strategies targeting neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa, Nagoya 464-8601, Japan.
- Promotion Office for Open Innovation, Institutes of Innovation for Future Society, Nagoya University, Furo-cho, Chikusa, Nagoya 464-8601, Japan.
ORCID-Profile: Andres D Maturana, Masaki Kita
Förderung
- Japan Society for the Promotion of Science
- Astellas Foundation for Research on Metabolic Disorders
- Daiichi Sankyo Foundation of Life Science
- The Naito Foundation
- JSPS
- Naito Foundation
Zitieren
APA
Hara, N., Sadamoto, C., Fukuoka, R., Yano, Y., Maturana, A. D., & Kita, M. (2025). In Silico Binding Mode Analysis of Blarina Paralytic Peptides with the Human T-Type Ca Channel hCav3.2. Toxins, 17(11), 549. https://doi.org/10.3390/toxins17110549
Vancouver
Hara N, Sadamoto C, Fukuoka R, Yano Y, Maturana AD, Kita M. In Silico Binding Mode Analysis of Blarina Paralytic Peptides with the Human T-Type Ca Channel hCav3.2. Toxins. 2025;17(11):549. doi:10.3390/toxins17110549
BibTeX
@article{Hara2025,
author = {Hara, Nozomi and Sadamoto, Chihiro and Fukuoka, Ryo and Yano, Yusuke and Maturana, Andres D and Kita, Masaki},
title = {In Silico Binding Mode Analysis of Blarina Paralytic Peptides with the Human T-Type Ca Channel hCav3.2},
journal = {Toxins},
year = {2025},
volume = {17},
number = {11},
pages = {549},
doi = {10.3390/toxins17110549}
}
EUVIMED